Inari Medical today announced a definitive agreement to purchase LimFlow Medical for up to $415 million. The deal comes just weeks after Paris-based LimFlow won FDA premarket approval (PMA) for its breakthrough system to treat chronic limb-threatening ischemia (CLTI). San Jose, California–based Inari said it expects to complete the acquisition by the end of 2023. […]
Longitude Capital
Calhoun Vision raises $69m for ‘adjustable’ IOL
Calhoun Vision said today that it raised a $69 million funding round for its ‘light-adjustable’ intra-ocular lens, with $52 million coming from a new round of financing and $17 million in a debt conversion. The round was led by Longitude Capital, with H.I.G. BioVentures, Balance Point Capital Partners, and RA Capital Management as co-investors. “This […]